Histological evaluation of FOXP1 in T-cell lymphomas has demonstrated that higher FOXP1 expression leads to an improved overall survival in PTCL patients and may be associated with a less activated tumor phenotype [53]. Here, FOXP1 is linked to T-cell non-Hodgkin lymphoma.